Prevention & Chronic Conditions

Broadcast

Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano , Aaron Wong, et al

Watch time: 1h 3m 30s

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

VEGF-C and Cardiovascular Mortality in Patients Undergoing Drug-eluting Stent Implantation

Citation:

European Cardiology Review 2018;13(2):124.

Relationship Between VEGF-C Levels and Mortality in Patients with Peripheral Artery Disease

Citation:

European Cardiology Review 2018;13(2):123.

ISCP 2018 Best Posters

Citation:

European Cardiology Review 2018;13(2):120

Platelets and the Coagulation System

Citation:

European Cardiology Review 2018;13(2):112–4.